Danimer Scientific, Inc. (DNMR) Q3 2024 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals declining revenue and significant financial risks, including a gross loss and high debt levels. Despite partnerships and cost-saving initiatives, the negative impact of Starbucks' reallocation and lack of liquidity guidance are concerning. The Q&A section did not provide clarity, furthering uncertainties. While there are positive developments like partnerships and cost savings, these are overshadowed by financial instability and operational risks. The absence of a clear liquidity outlook and unresolved leadership transition contribute to a negative sentiment.
Key Financial Performance
Total Revenue $8.6 million, down from $10.9 million year-over-year, a decrease of 21% primarily due to the impact of Starbucks reallocation of their Nodax-based PHA straw business.
PHA-based Resin Sales $6.7 million, decreased by 22% or $1.8 million compared to the prior year, driven by the same Starbucks reallocation.
Gross Loss $7.3 million, slightly improved from a gross loss of $7.7 million in the prior year quarter.
Adjusted Gross Loss $2.3 million, improved from an adjusted gross loss of $2.6 million in the prior year quarter.
R&D and SG&A Expenses $6.6 million, consistent with the third quarter of last year.
Adjusted EBITDA Loss $8.9 million, an improvement over a loss of $9.3 million in the third quarter of 2023.
Unrestricted Cash and Cash Equivalents $22.2 million at the end of the third quarter.
Restricted Cash $14.1 million, mainly held for future interest payments under the senior secured term loan.
Excess Availability on Revolving Credit Agreement $4.8 million at the end of the third quarter.
Capital Expenditures $2.8 million in the current third quarter, slightly up from $2.7 million in the prior year.
Total Debt Balance $387.9 million, primarily from convertible senior notes, senior secured term loan, revolving credit agreement, and $46 million of new market tax credit loans.
Year-to-Date Adjusted EBITDA -$27.4 million through the third quarter.
Expected Full Year Adjusted EBITDA Between -$34.4 million and -$34.9 million, consistent with previous guidance.
Expected Full Year Capital Expenditures Between $8 million to $9 million, within previously disclosed guidance.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Product Launch: Soft launch of 100% compostable Skittles bag made with Nodax PHA-based resin during a Seattle Seahawks football game. Completion of second commercial shipment of compostable single-use coffee pod capsule resin in compliance with new EU regulations. Expansion of WinCup's phade brand to include cutlery, cups, and cup lids. Progress on significant cutlery award from a large global QSR chain, with plans to phase out petroleum-based plastic by end of 2025.
Market Expansion: Partnership with a large global QSR chain to supply bio-based and biodegradable plastic for single-use cutlery. Partnership with Delta Cafes for compostable coffee pod capsules. Collaboration with Eagle Beverage to manufacture single-use cutlery using Nodax-based PHA resin.
Operational Efficiency: Implemented cost savings initiatives exceeding $20 million since early 2022, including labor cost reductions and inventory optimization. Temporary suspension of operations at Danimer Catalytic Technologies to manage costs.
Strategic Shift: Focus on managing indebtedness levels and liquidity constraints as commercial ramp-up approaches. Search for a permanent CEO continues, with significant progress made by the executive committee.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Competitive Pressures: The company faces competitive pressures from other biopolymer manufacturers and traditional petroleum-based plastic producers, which could impact market share and pricing strategies.
Regulatory Issues: Compliance with new EU regulations regarding compostability standards for products, such as coffee pod capsules, poses a challenge but also an opportunity for growth.
Supply Chain Challenges: Disruptions in order patterns due to Starbucks' reapportionment of their Nodax-based PHA straw business negatively impacted third quarter results.
Economic Factors: The company is managing significant indebtedness levels and near-term liquidity constraints as it ramps up commercial operations, which could affect financial stability.
Liquidity Risks: The company is focused on managing cash flow and has implemented cost-saving measures exceeding $20 million since early 2022 to preserve liquidity.
Debt Management: The company is analyzing various transactions to reduce debt and improve liquidity, but acknowledges that these measures may not be successful.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Commercial Plan Execution: Danimer is focused on executing its commercial plan, bolstering innovation, and positioning the company for long-term growth.
Partnerships and Product Launches: Significant partnerships with major brands like a global QSR chain, Delta Cafes, WinCup, and Mars Wrigley are progressing, with product launches including compostable cutlery and coffee pod capsules.
Cost Savings Initiatives: Implemented run rate cost savings in excess of $20 million since early 2022, including reductions in discretionary spending and labor costs.
Fourth Quarter Adjusted EBITDA: Expected to be between -$7 million and -$7.5 million, resulting in a full year adjusted EBITDA total of -$34.4 million to -$34.9 million.
Full Year CapEx Guidance: Expected to be between $8 million to $9 million, supporting existing commitments related to the Bainbridge greenfield facility and maintenance expenditures.
Liquidity Outlook: The company is not providing a year-end 2024 liquidity outlook at this time due to ongoing evaluations of transactions to provide additional liquidity.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Shareholder Return Plan: The company is focused on managing its indebtedness levels and liquidity constraints while analyzing various transactions and mechanisms designed to reduce debt and provide additional liquidity. However, no specific share buyback or dividend program was mentioned.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you provide an update on the significant cutlery award from a large global QSR chain?
A:Our significant cutlery award from a large global QSR chain continues to progress well and is in line with the end customers ramp plan. This QSR plans to completely phase out petroleum-based plastic in favor of bio-based and biodegradable plastic for single-use cutlery across all of its U.S.-based restaurants by the end of 2025.
Q:What were the financial results for the third quarter?
A:Total revenue was $8.6 million in the third quarter, down from $10.9 million in the prior year quarter. PHA-based resin sales of $6.7 million decreased by 22% compared to the prior year.
Q:What actions are being taken to manage liquidity and debt?
A:We have implemented run rate cost savings in excess of $20 million since early 2022 and are analyzing a variety of transactions and mechanisms designed to reduce debt and provide additional liquidity.
Q:What is the outlook for adjusted EBITDA for the fourth quarter?
A:We expect our fourth quarter adjusted EBITDA to be between a range of minus $7 million and minus $7.5 million.
Q:Can you provide a year-end 2024 liquidity outlook?
A:The company is not providing a year-end 2024 liquidity outlook at this time.
Q:Review of Unclear Management Responses
A:Management did not provide a year-end 2024 liquidity outlook, which lacked clarity on future financial positioning.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Altice Chief
Altice Interim
Bainbridge greenfield
Beverage product
CEO
Eagle Beverage
Interim Chief
QSR
Slide presentation
Starbucks
asset
bag
capital project
cash sale
commitment
cost saving
credit agreement
facility
harbor
initiative
liquidity
mechanism debt
mid
mold
order
petroleum
plan
position
pound resin
ramp
search
spending
straw
teammate
transaction mechanism
variety transaction
world challenge
DNMR Transcript
Danimer Scientific, Inc. (DNMR) Q3 2024 Earnings Call Transcript
Unknown11-20
The earnings call reveals declining revenue and significant financial risks, including a gross loss and high debt levels. Despite partnerships and cost-saving initiatives, the negative impact of Starbucks' reallocation and lack of liquidity guidance are concerning. The Q&A section did not provide clarity, furthering uncertainties. While there are positive developments like partnerships and cost savings, these are overshadowed by financial instability and operational risks. The absence of a clear liquidity outlook and unresolved leadership transition contribute to a negative sentiment.
Danimer Scientific, Inc (DNMR) Q2 2024 Earnings Call Transcript
Unknown8-10
The earnings call reveals several challenges: a significant revenue decline, negative EBITDA guidance, and supply chain issues impacting results. Despite optimistic future PHA revenue forecasts and cost-saving measures, competitive pressures, regulatory disruptions, and liquidity concerns pose risks. The Q&A session highlighted management's vague responses, adding uncertainty. The warrant program's potential benefits are overshadowed by a high debt burden. Overall, the negative financial performance and management's unclear guidance suggest a negative stock price movement in the short term.
Danimer Scientific, Inc. (DNMR) Q1 2024 Earnings Call Transcript
Unknown5-8
The earnings call indicates several challenges: significant revenue decline due to external conflicts, high debt levels, and liquidity concerns. While PHA revenues increased, overall sales dropped, and financial losses persist. The unresolved DOE loan adds uncertainty, and management's vague responses in the Q&A further dampen confidence. Despite some cost reductions and potential future operational improvements, the immediate outlook is negative, likely leading to a stock price decline.
Danimer Scientific, Inc. (DNMR) Q4 2023 Earnings Call Transcript
Unknown3-28
The earnings call summary presents a mixed picture: positive developments such as potential DOE loan approval, strong demand, and cost reductions are offset by unclear guidance and the need for additional equity. The Q&A reveals optimism about future demand and partnerships but also highlights uncertainties in execution timing and financial commitments. Without specific guidance and given the lack of market cap data, the sentiment remains neutral.
DNMR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
